10-K Filing

HEALTHTECH SOLUTIONS, INC./UT CIK: 1307624 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0001262463-22-000054`
Period End Date	20211231
Filing Date	20220415
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	hltt10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 43 Cash Flow Statement 51 Stockholders Equity 20

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$129.00K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.11K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$138.00K	USD	Point-in-time
Loan receivable	`LoansReceivableHeldForSaleAmount`	-	USD	Point-in-time
Loan receivable	`LoansReceivableHeldForSaleAmount`	$168.00K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$139.00K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$313.10K	USD	Point-in-time
Investment in and advance to non-consolidated affiliate	`DueFromAffiliateNoncurrent`	$110.00K	USD	Point-in-time
Investment in and advance to non-consolidated affiliate	`DueFromAffiliateNoncurrent`	-	USD	Point-in-time
Total Long Term Assets	`TotalLongTermAssets`	$110.00K	USD	Point-in-time
Total Long Term Assets	`TotalLongTermAssets`	-	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	-	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	$25.93K	USD	Point-in-time
Total Assets	`Assets`	$423.10K	USD	Point-in-time
Total Assets	`Assets`	$164.92K	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$80.17K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$733.74K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	66.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Accrued interest	`InterestPayableCurrent`	-	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$3.79K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	66.97M	shares	Point-in-time
Loans from shareholders	`LoansFromShareholders`	-	USD	Point-in-time
Loans from shareholders	`LoansFromShareholders`	$336.92K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$83.96K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.07M	USD	Point-in-time
Convertible debentures payable, net of discount	`ConvertibleDebtNoncurrent`	$305.68K	USD	Point-in-time
Convertible debentures payable, net of discount	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$337.87K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$643.56K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.07M	USD	Point-in-time
Total Liabilities	`Liabilities`	$727.52K	USD	Point-in-time
Series A preferred stock, $0.001 par value, 2,000,000 authorized, 110,520 and 156,837 issued and outstanding as of December 31, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$110.00	USD	Point-in-time
Series A preferred stock, $0.001 par value, 2,000,000 authorized, 110,520 and 156,837 issued and outstanding as of December 31, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$157.00	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 66,965,933 and 9,701,269 issued and outstanding as of December, 2021 and December 31, 2020, respectively	`CommonStockValue`	$66.97K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 66,965,933 and 9,701,269 issued and outstanding as of December, 2021 and December 31, 2020, respectively	`CommonStockValue`	$9.70K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$866.25K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.55M	USD	Point-in-time
Stockholders' Equity (Deficit):	`StockholdersEquity`	$-562.60K	USD	Point-in-time
Stockholders' Equity (Deficit):	`StockholdersEquity`	$134.17K	USD	Point-in-time
Stockholders' Equity (Deficit):	`StockholdersEquity`	$-647.56K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$164.92K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$423.10K	USD	Point-in-time

Income Statement 43 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$115.40K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.90M	USD	Annual
General and administrative-related party	`OtherGeneralAndAdministrativeExpense`	$2.60M	USD	Annual
General and administrative-related party	`OtherGeneralAndAdministrativeExpense`	$129.73K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$348.77K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$159.77K	USD	Annual
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$322.00K	USD	Annual
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$77.06K	USD	Annual
Amortization	`AdjustmentForAmortization`	$38.89K	USD	Annual
Amortization	`AdjustmentForAmortization`	$25.93K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$5.01M	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$709.86K	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-5.01M	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-709.86K	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$367.14K	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$19.58K	USD	Annual
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	$-2.77K	USD	Annual
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	$-2.93M	USD	Annual
Total Other Expenses	`NonoperatingIncomeExpense`	$3.30M	USD	Annual
Total Other Expenses	`NonoperatingIncomeExpense`	$22.35K	USD	Annual
Loss from continuing operations before tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-732.21K	USD	Annual
Loss from continuing operations before tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-8.31M	USD	Annual
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	Annual
Loss from continuing operations	`NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic`	$-8.31M	USD	Annual
Loss from continuing operations	`NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic`	$-732.21K	USD	Annual
Loss from Discontinued Operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-668.96K	USD	Annual
Loss from Discontinued Operations, net of taxes	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Loss from disposal	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-134.11K	USD	Annual
Loss from disposal	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	Annual
Total Loss from Discontinued Operations:	`IncomeLossFromDiscontinuedOperationNetOfTax`	$-803.07K	USD	Annual
Net Loss	`ProfitLoss`	$-9.11M	USD	Annual
Net Loss	`ProfitLoss`	$-732.21K	USD	Annual
Loss from continuing operations per common share - basic and diluted	`LossFromContinuingOperationsPerCommonShareBasicAndDiluted`	$-0.61	USD	Annual
Loss from continuing operations per common share - basic and diluted	`LossFromContinuingOperationsPerCommonShareBasicAndDiluted`	$-0.28	USD	Annual
Loss from discontinued operations per common share - basic and diluted	`LossFromDiscontinuedOperationsPerCommonShareBasicAndDiluted`	$-0.03	USD	Annual
Loss from discontinued operations per common share - basic and diluted	`LossFromDiscontinuedOperationsPerCommonShareBasicAndDiluted`	-	USD	Annual
Net loss per share - basic and diluted	`NetLossPerShareBasicAndDiluted`	$-0.61	USD	Annual
Net loss per share - basic and diluted	`NetLossPerShareBasicAndDiluted`	$-0.31	USD	Annual
Weighted average shares outstanding Basic and diluted	`WeightedAverageSharesOutstandingBasicAndDiluted`	29.43M	shares	Annual
Weighted average shares outstanding Basic and diluted	`WeightedAverageSharesOutstandingBasicAndDiluted`	1.20M	shares	Annual

Cash Flow Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-9.11M	USD	Annual
Net loss	`ProfitLoss`	$-732.21K	USD	Annual
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-668.96K	USD	Annual
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-8.44M	USD	Annual
Amortization expense	`AdjustmentForAmortization`	$38.89K	USD	Annual
Amortization expense	`AdjustmentForAmortization`	$25.93K	USD	Annual
Issuance of common stock	`IssuanceOfCommonStock`	-	USD	Annual
Issuance of common stock	`IssuanceOfCommonStock`	$3.23M	USD	Annual
Change in fair value of derivative liability	`GainLossOnSaleOfDerivatives`	$-2.77K	USD	Annual
Change in fair value of derivative liability	`GainLossOnSaleOfDerivatives`	$-2.93M	USD	Annual
Loss on disposal of subsidiary	`GainLossOnDispositionOfAssets1`	$-134.11K	USD	Annual
Amortization of discount on convertible debentures	`AmortizationOfDebtDiscountPremium`	$9.28K	USD	Annual
Amortization of discount on convertible debentures	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Interest expense capitalized to convertible debentures payable	`PaidInKindInterest`	$6.51K	USD	Annual
Interest expense capitalized to convertible debentures payable	`PaidInKindInterest`	-	USD	Annual
Non-cash interest	`OtherNoncashExpense`	$367.14K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-10.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-128.06K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$3.79K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$653.58K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$43.77K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-637.20K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.22M	USD	Annual
Advances to divested subsidiary	`AdvancesToDivestedSubsidiary`	$913.07K	USD	Annual
Payment of loan receivable	`PaymentsForProceedsFromLoansReceivable`	$168.00K	USD	Annual
Cash paid upon reverse merger	`RepaymentsOfOtherShortTermDebt`	$235.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-235.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.08M	USD	Annual
Proceeds of loans from shareholders	`ProceedsOfLoansFromShareholders`	$105.75K	USD	Annual
Proceeds of loans from shareholders	`ProceedsOfLoansFromShareholders`	$336.92K	USD	Annual
Proceeds from convertible debenture	`ProceedsFromConvertibleDebt`	$625.00K	USD	Annual
Proceeds from convertible debenture	`ProceedsFromConvertibleDebt`	$50.00K	USD	Annual
Capital contributions	`ProceedsFromContributionsFromParent`	$4.56K	USD	Annual
Capital contributions	`ProceedsFromContributionsFromParent`	$270.44K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.79M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.79M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.18M	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$129.00K	USD	Annual
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-121.89K	USD	Annual
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.11K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.11K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$61.00	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	Annual

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance at December 31, 2020	`StockholdersEquity`	$-562.60K	USD	Point-in-time
Balance at December 31, 2020	`StockholdersEquity`	$134.17K	USD	Point-in-time
Balance at December 31, 2020	`StockholdersEquity`	$-647.56K	USD	Point-in-time
Effect of reverse merger transaction	`StockIssuedDuringPeriodValueOther`	$-235.00K	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$3.23M	USD	Annual
Issuance of common stock for services, shares	`StockIssuedDuringPeriodSharesIssuedForServices`	1.50M	shares	Point-in-time
Issuance of common stock for services, shares	`StockIssuedDuringPeriodSharesIssuedForServices`	3.51M	shares	Annual
Issuance of common stock for cash proceeds	`StockIssuedDuringPeriodValueNewIssues`	$1.79M	USD	Annual
Issuance of common stock for cash proceeds, shares	`StockIssuedDuringPeriodSharesNewIssues`	3.51M	shares	Point-in-time
Issuance of common stock for cash proceeds, shares	`StockIssuedDuringPeriodSharesNewIssues`	8.96M	shares	1 Quarter
Conversion of Series A Preferred into common stock	`DebtConversionOriginalDebtAmount1`	-	USD	Annual
Conversion of Debentures into common stock	`ConversionOfStockAmountIssued1`	$4.00M	USD	Annual
Conversion of Debentures into common stock, shares	`ConversionOfStockSharesConverted1`	16,910.00	shares	Point-in-time
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$4.56K	USD	Annual
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$270.44K	USD	Annual
Net loss	`NetIncomeLoss`	$-732.21K	USD	Annual
Net loss	`NetIncomeLoss`	$-9.11M	USD	Annual
Balance at December 31, 2021	`StockholdersEquity`	$-562.60K	USD	Point-in-time
Balance at December 31, 2021	`StockholdersEquity`	$134.17K	USD	Point-in-time
Balance at December 31, 2021	`StockholdersEquity`	$-647.56K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.